One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-122980
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 56 |
Affiliation: Norton Healthcare, Western Pennsylvania Hospital, Allegheny Health Network, Albert Einstein College of Medicine, Montefiore Medical Center, Fred Hutch Cancer Center, Oregon Health & Science University, Roswell Park Cancer Institute, The University of Texas Southwestern Medical Center, Vanderbilt University, Cornell University, New York Hospital Queens, Presbyterian Hospital, NewYork–Presbyterian Hospital, The University of Texas MD Anderson Cancer Center, Mayo Clinic, Gabrail Cancer Center, Queen Elizabeth II Health Sciences Centre, Princess Margaret Cancer Centre, University of Southern California, University of Alberta, University of Ottawa, Ottawa Hospital, Hackensack University Medical Center, University of Chicago, Johns Hopkins Hospital, Johns Hopkins University, Yale University, Yale Cancer CenterPharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
